TY - JOUR AU - Bonnefoi, H. AU - Biganzoli, L. AU - Cufer, T. AU - Mauriac, L. AU - Hamilton, A. AU - Schaefer, P. AU - Piccart, M. PY - 2001 DA - 2001// TI - An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-FU (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer. JO - Breast Cancer Res Treat VL - 70 UR - https://doi.org/10.1023/A:1012530607649 DO - 10.1023/A:1012530607649 ID - Bonnefoi2001 ER -